Health Catalyst Capital

Represented Health Catalyst Capital, a venture capital fund focusing on healthcare technology and technology enabled services, in connection with its convertible preferred equity investment in Holmusk, a company dedicated to creating the largest real world evidence (RWE) platform in the fields of behavioral health and neuroscience, to improve care for patients and fuel innovation among pharma companies.